181 related articles for article (PubMed ID: 15168786)
1. Transepithelial electrical resistance is not a reliable measurement of the Caco-2 monolayer integrity in Transwell.
Mukherjee T; Squillantea E; Gillespieb M; Shao J
Drug Deliv; 2004; 11(1):11-8. PubMed ID: 15168786
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of absorption enhancers in Caco-2 cell monolayers.
Sakai M; Imai T; Ohtake H; Otagiri M
J Pharm Pharmacol; 1998 Oct; 50(10):1101-8. PubMed ID: 9821655
[TBL] [Abstract][Full Text] [Related]
3. Normal flora: living vehicles for non-invasive protein drug delivery.
Shao J; Kaushal G
Int J Pharm; 2004 Nov; 286(1-2):117-24. PubMed ID: 15501008
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.
Quan YS; Hattori K; Lundborg E; Fujita T; Murakami M; Muranishi S; Yamamoto A
Biol Pharm Bull; 1998 Jun; 21(6):615-20. PubMed ID: 9657048
[TBL] [Abstract][Full Text] [Related]
5. Online monitoring of transepithelial electrical resistance (TEER) in an apparatus for combined dissolution and permeation testing.
Muendoerfer M; Schaefer UF; Koenig P; Walk JS; Loos P; Balbach S; Eichinger T; Lehr CM
Int J Pharm; 2010 Jun; 392(1-2):134-40. PubMed ID: 20347022
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms for absorption enhancement of inhaled insulin by sodium taurocholate.
Johansson F; Hjertberg E; Eirefelt S; Tronde A; Hultkvist Bengtsson U
Eur J Pharm Sci; 2002 Oct; 17(1-2):63-71. PubMed ID: 12356421
[TBL] [Abstract][Full Text] [Related]
7. Novel oral absorption system containing polyamines and bile salts enhances drug transport via both transcellular and paracellular pathways across Caco-2 cell monolayers.
Mukaizawa F; Taniguchi K; Miyake M; Ogawara K; Odomi M; Higaki K; Kimura T
Int J Pharm; 2009 Feb; 367(1-2):103-8. PubMed ID: 18929635
[TBL] [Abstract][Full Text] [Related]
8. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C
Twarog C; Liu K; O'Brien PJ; Dawson KA; Fattal E; Illel B; Brayden DJ
Eur J Pharm Biopharm; 2020 Jul; 152():95-107. PubMed ID: 32387703
[TBL] [Abstract][Full Text] [Related]
9. Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers.
Liu DZ; LeCluyse EL; Thakker DR
J Pharm Sci; 1999 Nov; 88(11):1161-8. PubMed ID: 10564065
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships for enhancement of paracellular permeability by 2-alkoxy-3-alkylamidopropylphosphocholines across Caco-2 cell monolayers.
Liu DZ; Morris-Natschke SL; Kucera LS; Ishaq KS; Thakker DR
J Pharm Sci; 1999 Nov; 88(11):1169-74. PubMed ID: 10564066
[TBL] [Abstract][Full Text] [Related]
11. The effect of hypoxia/reoxygenation on the cellular function of intestinal epithelial cells.
Xu DZ; Lu Q; Kubicka R; Deitch EA
J Trauma; 1999 Feb; 46(2):280-5. PubMed ID: 10029034
[TBL] [Abstract][Full Text] [Related]
12. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
13. The effect of various absorption enhancers on tight junction in the human intestinal Caco-2 cell line.
Yu Q; Wang Z; Li P; Yang Q
Drug Dev Ind Pharm; 2013 Apr; 39(4):587-92. PubMed ID: 22656319
[TBL] [Abstract][Full Text] [Related]
14. Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.
Brayden DJ; Maher S; Bahar B; Walsh E
Eur J Pharm Biopharm; 2015 Aug; 94():194-206. PubMed ID: 26026287
[TBL] [Abstract][Full Text] [Related]
15. Docosahexaenoic acid and eicosapentaenoic acid-enriched phosphatidylcholine liposomes enhance the permeability, transportation and uptake of phospholipids in Caco-2 cells.
Hossain Z; Kurihara H; Hosokawa M; Takahashi K
Mol Cell Biochem; 2006 Apr; 285(1-2):155-63. PubMed ID: 16477371
[TBL] [Abstract][Full Text] [Related]
16. The effect of phospholipids and fatty acids on tight-junction permeability and bacterial translocation.
Sawai T; Drongowski RA; Lampman RW; Coran AG; Harmon CM
Pediatr Surg Int; 2001 May; 17(4):269-74. PubMed ID: 11409160
[TBL] [Abstract][Full Text] [Related]
17. Discovery of synergistic permeation enhancers for oral drug delivery.
Whitehead K; Karr N; Mitragotri S
J Control Release; 2008 Jun; 128(2):128-33. PubMed ID: 18433909
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of paracellular transport of heparin disaccharide across Caco-2 cell monolayers.
Cho SY; Kim JS; Li H; Shim C; Linhardt RJ; Kim YS
Arch Pharm Res; 2002 Feb; 25(1):86-92. PubMed ID: 11885699
[TBL] [Abstract][Full Text] [Related]
19. Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy.
Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M
J Pharm Sci; 1997 Jul; 86(7):779-85. PubMed ID: 9232516
[TBL] [Abstract][Full Text] [Related]
20. Modulation of tight junctions does not predict oral absorption of hydrophilic compounds: use of Caco-2 and Calu-3 cells.
Kamath AV; Morrison RA; Mathias NR; Dando SA; Marino AM; Chong S
Arch Pharm Res; 2007 Aug; 30(8):1002-7. PubMed ID: 17879754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
